Notice Regarding Issue of Hybrid Bonds to replace Senior Short Term Loan (Offering of Subordinated Bonds)
(WorldNews Japan)

OSAKA, JAPAN, February 15, 2019 - Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (`Takeda`) today announced that it filed with the Director of the Kanto Local Finance Bureau a shelf registration statement for the issuance of up to 500 billion Japanese yen aggregate principal amount of bonds and an amended shelf registration statement in connection with its potential public offering of hybrid bonds (subordinated bonds) (the `Hybrid Bonds`). This Hybrid bond issuance is to replace all or a part of the existing Short Term Loan (the `SSTL`) and won`t increase debt outstanding in total as shown on the table 1.1. The details are as follows. 1. Overviews Although Takeda has previously...